Companies: 10,795·Total market cap: $144.5T
Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.

MIRMNASDAQHealthcare● Active
$93.48
+$0.99(+1.07%)
Market Cap$4.7B
P/E Ratio—
52W High$114.99
52W Low$43.5
Cash on HandFinancialsRevenue

Mirum Pharmaceuticals, Inc. (MIRM) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MIRM · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$383.3M▲ +36.7% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$296.7M
cashAndCashEquivalents
Short-Term Investments
$86.6M
shortTermInvestments
YoY Change vs Prior Year
+36.7%
vs prior fiscal year
Latest Quarter
$386.3M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$383.3MCash on Hand
Total Debt$319.5MTotal Debt
Net Cash / Net Debt+$63.9MNet Cash Position
Cash vs Debt Ratio
Cash 55%Debt 45%

Mirum Pharmaceuticals, Inc. has a net cash position of $63.9M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$383.3M − $319.5M = +$63.9M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
MIRM annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$383.3M+36.7%
Dec 31, 2024$280.3M-2.1%
Dec 31, 2023$286.3M+88.7%
Dec 31, 2022$151.7M-3.1%
Dec 31, 2021$156.5M-32.5%
MIRM cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.8%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc.YOU
MIRM
$383.3M8.2%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Mirum Pharmaceuticals, Inc. (MIRM) cash on hand as of December 31, 2025 is $383.3M, comprising $296.7M in cash and cash equivalents (CCE) plus $86.6M in short-term investments — reported as Mirum Pharmaceuticals, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Mirum Pharmaceuticals, Inc. cash reserves or cash position.

Mirum Pharmaceuticals, Inc. annual cash on hand history shows increased +36.7% in 2025: increased +36.7% in 2025. Mirum Pharmaceuticals, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Mirum Pharmaceuticals, Inc. carries total debt of $319.5M against cash of $383.3M, resulting in a net cash position of +$63.9M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

MIRM cash on hand · 5 questions

As of December 31, 2025, Mirum Pharmaceuticals, Inc. (MIRM) has $383,327,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $296,683,000 in cash and cash equivalents (CCE) plus $86,644,000 in short-term investments. Latest quarter (March 31, 2026): $386,259,000. Data sourced from the annual 10-K filing via FMP.

MIRM cash on handMIRM cash reservesMIRM cash 2025how much cash does MIRM have

▸ Source: FMP /balance-sheet-statement · US GAAP · Mirum Pharmaceuticals, Inc. · Mirum Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025